A film by Jeffrey M. Smith - Narrated by Lisa Oz

Never-Before-Seen-Evidence points to genetically engineered foods as a major contributor to rising disease rates in the US population, especially among children. Gastrointestinal disorders, allergies, inflammatory diseases, and infertility are just some of the problems implicated in humans, pets, livestock, and lab animals that eat genetically modified soybeans and corn.

Monsanto's strong arm tactics, the FDA's fraudulent policies, and how the USDA ignores a growing health emergency are also laid bare. This sometimes shocking film may change your diet, help you protect your family, and accelerate the consumer tipping point against genetically modified organisms (GMOs). Don't miss this film!

A meta-analysis of properly performed previous studies on heart health and saturated fats concluded "there is no significant evidence for concluding that dietary saturated fat is associated with an increased risk of coronary heart disease or cardiovascular disease".

The saturated fat-high cholesterol myth over the last few decades has resulted in many Americans eating and drinking more low and no fat foods and beverages. Yet, heart disease rates have continued to rise along with obesity.

Dr. William Davis asserts in his article "A Headline You Will Never See: 60 Year Old Man Dies of Cholesterol" that cholesterol doesn't kill "any more than a bad paint job on your car could cause a fatal car accident."

Dr. Davis explains the cause of most heart attacks and coronary problems is atherosclerotic plaque from inflammation and calcium deposits, which can build up and rupture or clog the arteries. He and noted cardiologists Stephen Sinatra and Dwight Lundell have expressed the same viewpoint.

While there can be some cholesterol in the plaque, cholesterol itself is waxy and pliable. Cholesterol is important for brain matter, nerves and all other cellular structural components. Calcium deposits (calcification) in artery interiors are much worse components of plaque.

"Fortunately" for us (Americans), we aren't exposed to too much chemicals sprayed onto our foods. Or are we? Either way, is it safe to consume these Agrochemicals? Have you seen the statistics? It must all be caused by genetics, right? Click Here

Argentina has recently become a giant experiment in farming genetically modified (GM) Roundup Ready (RR) soy, soy that has been genetically modified to be tolerant to Roundup, Monsanto's formulation of the herbicide glyphosate. The Argentine government has been so eager to pull the country out of a deep economic recession that occurred in the 1990's, that it restructured its economy around GM soy grown for export, most of which goes to Europe to feed livestock. In 2009, GM soy was planted on 47 million acres; over half of Argentina's cultivated land, and sprayed with over 84 million gallons of glyphosate herbicide. Spraying is usually performed from the air which can cause problems many miles away.

Back in 2002, two years after the first big harvest of RR soy, residents and doctors in this soy producing areas began reporting serious health effects from glyphosate spraying, which included high rates of birth defects, infertility, stillbirths, miscarriages, and cancers. Environmental effects included killed food crops and livestock along with streams filled with dead fish.

New research, conducted on rodents, suggests that pre-menopausal hysterectomy with ovariectomy induces changes in the hippocampus (memory center of brain) making it hypersensitive to ischemic stressors (reduced blood flow). In contrast, ischemic stressors did not cause hippocampal damage in non-ovariectomized female rats or even gonadectomized male rats

The hippocampus, located in the temporal lobe of the brain, is responsible for working memory formation, storage and retrieval. Researchers have long known that damage to cells in the hippocampus cause significant problems in short-term, long-term and working memory, ranging from mild cognitive decline to complete impairment. Certain cells in the hippocampus are particularly sensitive to the amyloid protein buildup associated with Alzheimer's disease.

In the current study, removal of the ovaries and the associated long-term estradiol deprivation made the hippocampus hypersensitive to ischemic stressors and induced a myriad of events leading to significant hippocampal CA3 cell damage and cell death. The long term estradiol deprivation also led to increased amyloid production and associated neurodegeneration. As one might expect, damage and disruption to the hippocampus, the brain's memory center, was associated with the animal's ability to learn, remember and function.

Why is there still a vaccine/autism controversy? Because families have been blocked from getting into a REAL court to prove that vaccines have caused their child's autism.

The Canary Party presents a video on the corrupt Vaccine Injury Compensation Program to show how the federal government and pharmaceutical companies continue to get away with claiming that vaccines don't cause autism in the face of mounting evidence that they are doing just that in a growing number of children.

Paracetamol (acetaminophen) is the most commonly used medicine in pregnancy, yet there are very few studies that have investigated the possible long-term consequences for the child. A new study from the Norwegian Institute of Public Health suggests that long-term use of paracetamol during pregnancy may increase the risk of adverse effects on child development.

The study uses data from the Norwegian Mother and Child Cohort Study to investigate the effect of paracetamol during pregnancy on psychomotor development, behaviour and temperament at 3 years of age. Almost 3000 sibling pairs were included in the study.

The pancreas is a large organ that wraps around our gut, and produces the exact amount of insulin our bodies need when we eat - except when we start to develop diabetes, and insulin production slows down. Sydney scientists describe how a fat recycling system within pancreatic 'beta cells' determines the amount of insulin they secrete, and so may provide a target for future diabetes therapies.

A small structure inside the beta cell, known as a 'lysosome', behaves like an intracellular recycling unit. It breaks down unwanted fats and proteins in such a way that they can be re-used.

PhD student Gemma Pearson and Professor Trevor Biden from Sydney's Garvan Institute of Medical Research showed that when they prevented lysosomes from breaking down fat, beta cells secreted more insulin. Their study is published in Diabetologia, now online.

While this is a very early stage cell biology story, it nonetheless holds promise, and encourages the scientific community to look at diabetes therapies through a fatty lens.

© Shermali Gunawardena
Materials move smoothly through the brain cells of a fruit fly larvae (left). But when scientists reduced the levels of the protein presenilin and the enzyme GSK-3B present in the nerve, tiny organic bubbles called vesicles began moving in an uncoordinated fashion and became trapped (right).

Study shows how the wrong levels of a protein linked with Alzheimer's disease can lead to dangerous blockages in brain cells.

Scientists have known for some time that a protein called presenilin plays a role in Alzheimer's disease, and a new study reveals one intriguing way this happens.

It has to do with how materials travel up and down brain cells, which are also called neurons.

In an Oct. 8 paper in Human Molecular Genetics, University at Buffalo researchers report that presenilin works with an enzyme called GSK-3ß to control how fast materials - like proteins needed for cell survival - move through the cells.

"If you have too much presenilin or too little, it disrupts the activity of GSK-3ß, and the transport of cargo along neurons becomes uncoordinated," says lead researcher Shermali Gunawardena, PhD, an assistant professor of biological sciences at UB. "This can lead to dangerous blockages."

While it's been known for over a century that iron deposits in the brain play a role in the pathology of Multiple Sclerosis (MS), new imaging research from Western University (London, Canada) helps to answer the question of whether these accumulations are a cause or consequence of the disease. The study led by Ravi Menon, PhD, of the Robarts Research Institute found iron deposits in deep gray matter, suggesting the accumulation occurs very early in the disease course. The researchers also found evidence casting further doubt on the controversial liberation therapy for MS. The research is in early publication online in Multiple Sclerosis and Related Disorders.


Menon and PhD candidate Matthew Quinn used 3-Tesla Magnetic Resonance Imaging (MRI) to scan 22 patients with clinically isolated syndrome (CIS). These are patients who've had a single clinical attack, at least half of whom will go on to be diagnosed with MS. The others may have a different disease. Sixteen age and sex matched controls were also studied.

"We wanted to know if the iron deposits happen early in the process, or whether it's something that accumulates with time as the disease progresses," says Menon, who holds a Canada Research Chair in Functional Magnetic Imaging. "We also studied the veins that drain from the brain and looked for a correlation between the diameter of of these veins and iron accumulation. One of the reasons to do this, of course was the hypothesis proposed by Paolo Zamboni that if you had narrow jugular veins, this would give rise to additional iron and in turn cause MS."

I've seen several pharmaceutical videos about ADHD lately. One started with a cartoon that resembled a "Simpsons" episode. I initially thought it was a gag. It appeared to be a typical presentation about a drug with the usual casual fast-talk about side effects that included death from a stroke. It was so straightforward yet insidious and comical, that it simply had to be a satire. I enjoyed the presentation right up to the end, only to find that it was real. It was an ad that had nothing to do with ADHD. The drug goes under the name of Abilify and was supposed to be given along with an antidepressant when the antidepressant alone wasn't working. The video got me thinking of how I've always wanted to see a satire of this type of drug ad. It would be so refreshing to see a cartoon that would bash the drug for a change.

"Saying no to drugs" also requires saying "yes" to something else. That something else is nutrition, properly employed.

Then came the video itself, "ADHD in the Workplace." It was presented by a doctor, garbed not in the typical stethoscope and white lab coat, but in a casual open-necked shirt, giving the viewer the feeling, "I'm really just one of you, not a pompous M.D." He described the symptoms of ADHD. The message seemed to be that if you are restless and have trouble concentrating, you probably have this common disorder. It didn't mention that these symptoms are normal for most people who are distracted or anxious, and often a consequence of deficits of essential nutrients. Now, the workplace has to adjust to your problem. For relief of restlessness, move around and go to the restroom. This advice almost sounded like the cliché, "hang around the water cooler." To relieve your inability to concentrate, wear earphones. Then the advice, "You may even be eligible for workman's compensation" which could support treatment with taxpayers' money.